These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 21805041
1. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z, Gao F, Kong Y, Xiao GG, Wang Q. Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041 [Abstract] [Full Text] [Related]
2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [Abstract] [Full Text] [Related]
3. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. Yu DQ, Yi YF. Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710 [Abstract] [Full Text] [Related]
4. Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines. Wang J, Wang H, Zhao L, Fan S, Yang Z, Gao F, Chen L, Xiao GG, Molnár J, Wang Q. Anticancer Res; 2010 Sep; 30(9):3593-8. PubMed ID: 20944142 [Abstract] [Full Text] [Related]
5. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Hepatogastroenterology; 2008 Sep; 55(86-87):1530-6. PubMed ID: 19102336 [Abstract] [Full Text] [Related]
6. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. Miracco C, Maellaro E, Pacenti L, Del Bello B, Valentini MA, Rubegni P, Pirtoli L, Volpi C, Santopietro R, Tosi P. Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796 [Abstract] [Full Text] [Related]
7. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma]. Leng WD, Wang DZ, Feng G, He J. Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692 [Abstract] [Full Text] [Related]
8. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines. Bottke D, Koychev D, Busse A, Heufelder K, Wiegel T, Thiel E, Hinkelbein W, Keilholz U. Radiat Res; 2008 Jul; 170(1):41-8. PubMed ID: 18582150 [Abstract] [Full Text] [Related]
9. [Coexpression and clinical significance of multi-drug resistance factors in lung cancer]. Huo J, Che C, Huang Q. Zhongguo Fei Ai Za Zhi; 2004 Jun 20; 7(3):218-21. PubMed ID: 21232222 [Abstract] [Full Text] [Related]
10. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N, Lam YM, Pym J, Campling BG. Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677 [Abstract] [Full Text] [Related]
11. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts. Kolfschoten GM, Hulscher TM, Pinedo HM, Boven E. Br J Cancer; 2000 Oct 01; 83(7):921-7. PubMed ID: 10970695 [Abstract] [Full Text] [Related]
12. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis]. Cao DY, Shen K, Yang JX, Guan J. Zhonghua Yi Xue Za Zhi; 2007 Jul 03; 87(25):1738-41. PubMed ID: 17919376 [Abstract] [Full Text] [Related]
13. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma]. Yu SP, Xiong YY, Tian SF. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar 03; 26(3):165-8. PubMed ID: 12816683 [Abstract] [Full Text] [Related]
14. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance. Xiang F, Yu W, Shen Y, Wu C, Wang Y. Zhongguo Fei Ai Za Zhi; 2007 Oct 20; 10(5):398-405. PubMed ID: 21126409 [Abstract] [Full Text] [Related]
15. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. Ikeda K, Oka M, Narasaki F, Fukuda M, Nakamura T, Nagashima S, Terashi K, Sato S, Kawabata S, Mizuta Y, Soda H, Kohno S. Anticancer Res; 1998 Oct 20; 18(4C):3077-80. PubMed ID: 9713513 [Abstract] [Full Text] [Related]
16. [Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer]. Zhang L, Yang H, Dong D. Zhongguo Fei Ai Za Zhi; 2006 Feb 20; 9(1):60-4. PubMed ID: 21144284 [Abstract] [Full Text] [Related]
17. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms. Zhao D, Jiang Y, Dong X, Liu Z, Qu B, Zhang Y, Ma N, Han Q. Biomed Pharmacother; 2011 Aug 20; 65(5):354-8. PubMed ID: 21775093 [Abstract] [Full Text] [Related]
18. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases. de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J. Anticancer Res; 1993 Aug 20; 13(5A):1425-30. PubMed ID: 7902062 [Abstract] [Full Text] [Related]
19. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Giaccone G, Gazdar AF, Beck H, Zunino F, Capranico G. Cancer Res; 1992 Apr 01; 52(7):1666-74. PubMed ID: 1312895 [Abstract] [Full Text] [Related]
20. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR. Zhang KG, Qin CY, Wang HQ, Wang JX, Wang QM. Hepatogastroenterology; 2012 Apr 01; 59(120):2672-6. PubMed ID: 23178631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]